SEOUL – North Korea confirmed on Monday that it had launched a missile Hwasong 12, the same weapon that once threatened to target US in Guam “with a blazing fire,” sparking fears that a nuclear-armed state could resume long-range missions.
Introduction of intermediate-range ballistic missile (IRBM) first reported https://www.reuters.com/world/asia-pacific/north-korea-fires-projectiles-into-sea-off-east-coast-yonhap -2022 -01-29 by South Korean and Japanese authorities on Sunday. It was North Korea’s seventh test this month https://www.reuters.com/world/asia-pacific/flurry-missile-tests-displays-nkoreas-increasingly-diverse-arsenal-2022-01-28 once the first time a powerful arrow was launched nuclear of that size from 2017
The United States is concerned that an increase in North Korean missile tests could be a precursor to a re-examination of nuclear weapons and intercontinental ballistic missiles (ICBMs) and vows an unspecified response “designed to demonstrate our commitment to our partners,” a U.S. official told reporters in Washington. .
“It’s not just what they did yesterday, the fact that this comes after a series of tests this month,” the official said, while urging Pyongyang to join the direct talks unconditionally.
North Korea has said it is open to negotiations, but Washington’s downfall undermines its support for sanctions and joint military training and weapons development in South Korea and the region.
Among the many negotiations in 2018, which included conferences with the then US. President Donald Trump, North Korean leader Kim Jong Un has announced that his nuclear arsenal is complete and has said he will suspend nuclear tests and launch the country’s longest-range missiles.
Kim said he was no longer bound by the decision after the suspension of negotiations in 2019, and North Korea suggested that this month it resume such inspections because the United States was showing no signs of abandoning “hostile policies.”
It is not yet clear whether IRBMs like the Hwasong-12 have been included in Kim’s suspension, but no one has been tested since 2017.